Bilal Siddiqui

17PUBLICATIONS
90CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesMolecular targetsCardiology (incl. cardiovascular diseases)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 16, 2026
Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets from the Phase II Randomized EXTEND Trial.

|May 07, 2026
Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial.

|Mar 20, 2026
Correction: Navigating drug-drug interactions with apalutamide.

Bilal A Siddiqui, Karine Tawagi, Sarah Caulfield

|Feb 24, 2026
The path forward for T cell engagers in patients with prostate cancer.

Sumit K Subudhi, Bilal A Siddiqui, Kevin K Zarrabi

|Feb 18, 2026
Navigating drug-drug interactions with apalutamide.

Bilal A Siddiqui, Karine Tawagi, Sarah Caulfield

|Nov 07, 2025
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone Therapy.

Neha Venkatesh, Pankaj Kumar Chauhan, Sagar S Mukhida

Pageof 3

Frequent Collaborators

5 joint publications

Sumit K Subuhdi

4 joint publications

Sreyashi Basu

3 joint publications

Rebecca S Slack-Tidwell

2 joint publications

Shalini S Yadav